Portfolio Holdings Detail for ISIN IE0009QS7W62
| Stock Name / Fund | MSCI Wld Hlth US A |
| Issuer | |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | WHCA(EUR) Euronext Amsterdam |
Holdings detail for DGX
| Stock Name | Quest Diagnostics Incorporated |
| Ticker | DGX(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US74834L1008 |
Show aggregate DGX holdings
News associated with DGX
- O Shaughnessy Asset Management LLC Has $649,000 Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)
- O Shaughnessy Asset Management LLC raised its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,305 shares of the medical research company’s stock after buying an additional 596 shares […] - 2025-04-10 08:58:54
- Here's What to Expect From Quest Diagnostics’ Next Earnings Report
- Quest Diagnostics is expected to release its Q1 results this month, and analysts expect a single-digit surge in earnings. - 2025-04-07 11:37:40
- Insider Selling: Quest Diagnostics Incorporated (NYSE:DGX) CEO Sells $6,602,115.86 in Stock
- Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) CEO J. E. Davis sold 39,191 shares of the company’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $168.46, for a total value of $6,602,115.86. Following the completion of the transaction, the chief executive officer now […] - 2025-04-07 08:54:55
- Quest Diagnostics Incorporated (NYSE:DGX) SVP Sells $434,350.00 in Stock
- Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) SVP Karthik Kuppusamy sold 2,555 shares of the firm’s stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $170.00, for a total value of $434,350.00. Following the completion of the sale, the senior vice president now directly owns 10,575 […] - 2025-04-07 08:15:07
- Thrivent Financial for Lutherans Has $2.66 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
- Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,621 shares of the medical research company’s stock after selling 1,346 shares during the […] - 2025-03-28 08:20:53
- Commonwealth Equity Services LLC Grows Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
- Commonwealth Equity Services LLC boosted its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,368 shares of the medical research company’s stock after acquiring an additional […] - 2025-03-24 08:00:50
- Stocks Rally as Fed Chair Powell Says the US Economy Remains Strong
- The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +1.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.92%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.30%. March E-mini S&P futures (ESH25 ) are up +1.11%, and March E-mini Nasdaq futures... - 2025-03-20 13:45:49
- Stocks Jump as Fed Backs Rate-Cut Forecast
- The S&P 500 Index ($SPX ) (SPY ) today is up +1.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.96%. March E-mini S&P futures (ESH25 ) are up +1.59%, and March E-mini Nasdaq futures... - 2025-03-19 23:35:10
- Stocks Edge Higher as the Magnificent Seven Recover
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. March E-mini S&P futures (ESH25 ) are up +0.40%, and March E-mini Nasdaq futures... - 2025-03-19 19:54:48
- Stocks Push Higher Ahead of FOMC Meeting Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.64%. March E-mini S&P futures (ESH25 ) are up +0.47%, and March E-mini Nasdaq futures... - 2025-03-19 18:57:12
- Stocks Push Higher Ahead of FOMC Meeting Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.64%. March E-mini S&P futures (ESH25 ) are up +0.47%, and March E-mini Nasdaq futures... - 2025-03-19 18:52:57
- Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight
- Betting on AI-driven precision oncology companies presents a compelling long-term opportunity for investors. Some of the stocks in focus are BTAI, TEM and DGX. - 2025-03-19 18:13:00
- Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Independent Advisor Alliance
- Independent Advisor Alliance lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,414 shares of the medical research company’s stock after purchasing an additional 303 shares during […] - 2025-03-17 08:08:57
- Quest Diagnostics Incorporated (NYSE:DGX) Receives $178.23 Consensus PT from Brokerages
- Shares of Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fifteen ratings firms that are currently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and two have given a strong buy […] - 2025-03-17 05:54:51
- Atria Wealth Solutions Inc. Has $464,000 Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)
- Atria Wealth Solutions Inc. raised its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,075 shares of the medical research company’s stock after acquiring an additional 425 shares during the quarter. […] - 2025-02-28 09:34:58
- Wealthspire Advisors LLC Acquires 240 Shares of Quest Diagnostics Incorporated (NYSE:DGX)
- Wealthspire Advisors LLC boosted its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,693 shares of the medical research company’s stock after buying an additional 240 shares during the period. Wealthspire Advisors […] - 2025-02-27 09:41:12
- Are Wall Street Analysts Bullish on Quest Diagnostics Stock?
- Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-02-24 18:40:56
- Take the Zacks Approach to Beat the Markets: Nomura, Wells Fargo, Primo Brands in Focus
- Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months. - 2025-02-24 13:20:00
- Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Van ECK Associates Corp
- Van ECK Associates Corp lifted its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 980.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 24,198 shares of the medical research company’s stock after buying an additional 21,958 shares during the quarter. Van ECK Associates Corp’s holdings in Quest Diagnostics […] - 2025-02-20 08:37:00
- Brokerages Set Quest Diagnostics Incorporated (NYSE:DGX) Target Price at $177.69
- Shares of Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the fifteen brokerages that are covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the […] - 2025-02-20 06:46:48
- New Mexico Educational Retirement Board Trims Holdings in Quest Diagnostics Incorporated (NYSE:DGX)
- New Mexico Educational Retirement Board lessened its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.9% in the 4th quarter, Holdings Channel reports. The firm owned 5,303 shares of the medical research company’s stock after selling 100 shares during the period. New Mexico Educational Retirement Board’s holdings in Quest Diagnostics were worth $800,000 […] - 2025-02-19 09:03:47
- New York State Teachers Retirement System Decreases Position in Quest Diagnostics Incorporated (NYSE:DGX)
- New York State Teachers Retirement System lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 87,322 shares of the medical research company’s stock after selling 4,310 […] - 2025-02-18 11:36:49
- State of Alaska Department of Revenue Has $1.92 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX)
- State of Alaska Department of Revenue reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 32.6% in the 4th quarter, HoldingsChannel reports. The firm owned 12,726 shares of the medical research company’s stock after selling 6,155 shares during the period. State of Alaska Department of Revenue’s holdings in Quest Diagnostics were worth […] - 2025-02-12 09:34:50
- Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Mirae Asset Global Investments Co. Ltd.
- Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 27.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,229 shares of the medical research company’s stock after purchasing an additional 2,884 shares […] - 2025-02-11 11:03:08
- Quest Diagnostics Incorporated (NYSE:DGX) Holdings Trimmed by Retirement Systems of Alabama
- Retirement Systems of Alabama trimmed its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 24,166 shares of the medical research company’s stock after selling 294 shares during the period. Retirement […] - 2025-02-11 08:34:49
- Take the Zacks Approach to Beat the Markets: Urban Outfitters, Genesco, Costco in Focus
- Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months. - 2025-02-10 13:16:00
- Quest Diagnostics (NYSE:DGX) Lowered to Hold Rating by StockNews.com
- Quest Diagnostics (NYSE:DGX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. Several other brokerages also recently weighed in on DGX. Truist Financial upped their target price on Quest Diagnostics from $172.00 to $182.00 and gave the […] - 2025-02-06 09:19:04
- Quest Diagnostics (NYSE:DGX) Price Target Raised to $178.00
- Quest Diagnostics (NYSE:DGX – Free Report) had its price objective boosted by Mizuho from $177.00 to $178.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an outperform rating on the medical research company’s stock. Several other equities analysts have also commented on DGX. Morgan Stanley upgraded Quest Diagnostics from an […] - 2025-02-06 08:40:51
- Piper Sandler Reaffirms “Neutral” Rating for Quest Diagnostics (NYSE:DGX)
- Piper Sandler restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a research report report published on Monday,Benzinga reports. Piper Sandler currently has a $180.00 price target on the medical research company’s stock, up from their previous price target of $165.00. A number of other equities research analysts also recently […] - 2025-02-06 08:40:51
- Quest Diagnostics (NYSE:DGX) Price Target Raised to $170.00
- Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by investment analysts at UBS Group from $166.00 to $170.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. UBS Group’s price target would suggest a potential upside of 4.02% from […] - 2025-02-05 11:54:46
MSCI Wld Hlth US A DGX holdings
| Date | Number of DGX Shares Held | Base Market Value of DGX Shares | Local Market Value of DGX Shares | Change in DGX Shares Held | Change in DGX Base Value | Current Price per DGX Share Held | Previous Price per DGX Share Held |
|---|
| 2025-04-17 (Thursday) | 2,210 | USD 361,998 | USD 361,998 | | | | |
| 2025-04-16 (Wednesday) | 2,210 | USD 363,479 | USD 363,479 | 0 | USD -6,099 | USD 164.47 | USD 167.23 |
| 2025-04-15 (Tuesday) | 2,210 | USD 369,578 | USD 369,578 | 0 | USD -1,702 | USD 167.23 | USD 168 |
| 2025-04-14 (Monday) | 2,210 | USD 371,280 | USD 371,280 | 0 | USD 8,862 | USD 168 | USD 163.99 |
| 2025-04-11 (Friday) | 2,210 | USD 362,418 | USD 362,418 | 0 | USD 309 | USD 163.99 | USD 163.85 |
| 2025-04-10 (Thursday) | 2,210 | USD 362,109 | USD 362,109 | 0 | USD -464 | USD 163.85 | USD 164.06 |
| 2025-04-09 (Wednesday) | 2,210 | USD 362,573 | USD 362,573 | 0 | USD 9,415 | USD 164.06 | USD 159.8 |
| 2025-04-08 (Tuesday) | 2,210 | USD 353,158 | USD 353,158 | 0 | USD -9,967 | USD 159.8 | USD 164.31 |
| 2025-04-07 (Monday) | 2,210 | USD 363,125 | USD 363,125 | 0 | USD 287 | USD 164.31 | USD 164.18 |
| 2025-04-04 (Friday) | 2,210 | USD 362,838 | USD 362,838 | 0 | USD -8,354 | USD 164.18 | USD 167.96 |
| 2025-04-02 (Wednesday) | 2,210 | USD 371,192 | USD 371,192 | 0 | USD -2,917 | USD 167.96 | USD 169.28 |
| 2025-04-01 (Tuesday) | 2,210 | USD 374,109 | USD 374,109 | 0 | USD 177 | USD 169.28 | USD 169.2 |
| 2025-03-31 (Monday) | 2,210 | USD 373,932 | USD 373,932 | 0 | USD 4,133 | USD 169.2 | USD 167.33 |
| 2025-03-28 (Friday) | 2,210 | USD 369,799 | USD 369,799 | 0 | USD 2,939 | USD 167.33 | USD 166 |
| 2025-03-27 (Thursday) | 2,210 | USD 366,860 | USD 366,860 | 0 | USD -1,370 | USD 166 | USD 166.62 |
| 2025-03-26 (Wednesday) | 2,210 | USD 368,230 | USD 368,230 | 0 | USD 2,121 | USD 166.62 | USD 165.66 |
| 2025-03-25 (Tuesday) | 2,210 | USD 366,109 | USD 366,109 | 26 | USD 660 | USD 165.66 | USD 167.33 |
| 2025-03-24 (Monday) | 2,184 | USD 365,449 | USD 365,449 | 0 | USD 481 | USD 167.33 | USD 167.11 |
| 2025-03-21 (Friday) | 2,184 | USD 364,968 | USD 364,968 | 0 | USD 1,419 | USD 167.11 | USD 166.46 |
| 2025-03-20 (Thursday) | 2,184 | USD 363,549 | USD 363,549 | 0 | USD -3,385 | USD 166.46 | USD 168.01 |
| 2025-03-19 (Wednesday) | 2,184 | USD 366,934 | USD 366,934 | 0 | USD -9,697 | USD 168.01 | USD 172.45 |
| 2025-03-18 (Tuesday) | 2,184 | USD 376,631 | USD 376,631 | 0 | USD -2,249 | USD 172.45 | USD 173.48 |
| 2025-03-17 (Monday) | 2,184 | USD 378,880 | USD 378,880 | 0 | USD 7,251 | USD 173.48 | USD 170.16 |
| 2025-03-14 (Friday) | 2,184 | USD 371,629 | USD 371,629 | 0 | USD 2,926 | USD 170.16 | USD 168.82 |
| 2025-03-13 (Thursday) | 2,184 | USD 368,703 | USD 368,703 | 0 | USD 5,242 | USD 168.82 | USD 166.42 |
| 2025-03-12 (Wednesday) | 2,184 | USD 363,461 | USD 363,461 | 0 | USD -3,779 | USD 166.42 | USD 168.15 |
| 2025-03-11 (Tuesday) | 2,184 | USD 367,240 | USD 367,240 | 0 | USD -10,854 | USD 168.15 | USD 173.12 |
| 2025-03-10 (Monday) | 2,184 | USD 378,094 | USD 378,094 | 0 | USD -5,329 | USD 173.12 | USD 175.56 |
| 2025-03-07 (Friday) | 2,184 | USD 383,423 | USD 383,423 | -53 | USD -1,363 | USD 175.56 | USD 172.01 |
| 2025-03-05 (Wednesday) | 2,237 | USD 384,786 | USD 384,786 | | | | |
| 2024-11-12 (Tuesday) | 2,866 | USD 463,432 | USD 463,432 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of DGX by for IE0009QS7W62
Show aggregate share trades of DGX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-03-25 | BUY | 26 | | | 165.660* | | 169.76 |
| 2025-03-07 | SELL | -53 | | | 175.560* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of DGX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-04-17 | 297,124 | 0 | 590,088 | 50.4% |
| 2025-04-16 | 351,360 | 5 | 553,069 | 63.5% |
| 2025-04-15 | 235,072 | 0 | 378,494 | 62.1% |
| 2025-04-14 | 376,350 | 0 | 687,321 | 54.8% |
| 2025-04-11 | 228,217 | 0 | 692,628 | 32.9% |
| 2025-04-10 | 290,815 | 40 | 625,680 | 46.5% |
| 2025-04-09 | 422,166 | 5 | 881,319 | 47.9% |
| 2025-04-08 | 417,104 | 16 | 712,385 | 58.6% |
| 2025-04-07 | 518,149 | 40 | 877,575 | 59.0% |
| 2025-04-04 | 637,897 | 0 | 1,161,743 | 54.9% |
| 2025-04-03 | 304,267 | 0 | 741,302 | 41.0% |
| 2025-04-02 | 167,417 | 24 | 335,735 | 49.9% |
| 2025-04-01 | 335,753 | 0 | 471,907 | 71.1% |
| 2025-03-31 | 293,453 | 100 | 535,314 | 54.8% |
| 2025-03-28 | 282,349 | 29 | 452,663 | 62.4% |
| 2025-03-27 | 153,130 | 0 | 266,426 | 57.5% |
| 2025-03-26 | 131,307 | 75 | 213,743 | 61.4% |
| 2025-03-25 | 162,056 | 0 | 249,917 | 64.8% |
| 2025-03-24 | 136,510 | 25 | 223,904 | 61.0% |
| 2025-03-21 | 240,729 | 130 | 296,075 | 81.3% |
| 2025-03-20 | 241,257 | 23 | 321,692 | 75.0% |
| 2025-03-19 | 397,317 | 3,514 | 507,721 | 78.3% |
| 2025-03-18 | 372,563 | 20 | 525,430 | 70.9% |
| 2025-03-17 | 300,057 | 0 | 426,546 | 70.3% |
| 2025-03-14 | 266,456 | 0 | 529,708 | 50.3% |
| 2025-03-13 | 394,491 | 0 | 565,337 | 69.8% |
| 2025-03-12 | 332,972 | 0 | 712,952 | 46.7% |
| 2025-03-11 | 271,775 | 0 | 489,574 | 55.5% |
| 2025-03-10 | 226,811 | 60 | 604,647 | 37.5% |
| 2025-03-07 | 219,171 | 100 | 358,709 | 61.1% |
| 2025-03-06 | 221,539 | 0 | 318,250 | 69.6% |
| 2025-03-05 | 232,361 | 0 | 506,099 | 45.9% |
| 2025-03-04 | 351,701 | 72 | 508,613 | 69.1% |
| 2025-03-03 | 305,746 | 0 | 489,803 | 62.4% |
| 2025-02-28 | 185,726 | 357 | 349,663 | 53.1% |
| 2025-02-27 | 289,094 | 0 | 420,141 | 68.8% |
| 2025-02-26 | 196,080 | 0 | 304,819 | 64.3% |
| 2025-02-25 | 458,681 | 0 | 563,313 | 81.4% |
| 2025-02-24 | 253,447 | 500 | 341,882 | 74.1% |
| 2025-02-21 | 183,895 | 0 | 226,190 | 81.3% |
| 2025-02-20 | 343,588 | 0 | 397,469 | 86.4% |
| 2025-02-19 | 438,918 | 893 | 588,012 | 74.6% |
| 2025-02-18 | 298,936 | 1,814 | 353,999 | 84.4% |
| 2025-02-14 | 315,035 | 0 | 422,104 | 74.6% |
| 2025-02-13 | 226,370 | 0 | 398,985 | 56.7% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.